VaramirStart free · no cardSign in
AQST as of Nov 1 · 10:50 ET
AQSTNasdaqPharmaceutical Preparations

Aquestive Therapeutics, Inc. · Brief

Next report

3 days

Nov 4 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±17.3%
avg realized
±6.7%
Jan 13 '25±17.6%▲+0.97%×0.06
Mar 5 '25±23.2%▼−7.53%×0.32
May 12 '25±14.9%▼−19.65%×1.32
Aug 11 '25±32.2%▼−2.07%×0.06
Q3 FY25±16.2%▲+2.17%×0.13
Q1 FY26±14.1%▼−2.52%×0.18
May 13 '26±7.7%▲+14.53%×1.88
Q2 FY26±12.4%▼−4.08%×0.33
quarterimplied−35%0+35%realized×
Q2 FY26±12.4%▼−4.08%×0.33
May '26±7.7%▲+14.53%×1.88
Q1 FY26±14.1%▼−2.52%×0.18
Q3 FY25±16.2%▲+2.17%×0.13
Aug '25±32.2%▼−2.07%×0.06
May '25±14.9%▼−19.65%×1.32
2 older reports
Mar '25±23.2%▼−7.53%×0.32
Jan '25±17.6%▲+0.97%×0.06
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 4

186managers reporting a position in the latest quarterly filings13F · Jun 30 '26
24managers whose positions together make up four fifths of reported value13F · Jun 30 '26

Bear2 of 4

73.00%share of revenue from the largest disclosed customer IndiviorSEC filings
6 of 8recent reports where the move came in under the options implied rangeEarnings history
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

AQST report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±13.9% into Nov 4 earnings (Oct 21 close).Source
Oct 148-KMaterial agreement: License Agreement and Supply Agreement with Eton Pharmaceuticals, Inc.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.